Novartis on 5 of the Company’s Key ESG Achievements in 2021

Originally published on LinkedIn. Novartis Pharmaceuticals is a Fair360, formerly DiversityInc Hall of Fame company.


Novartis Pharmaceuticals is accelerating its journey toward expanding access to medicines, improving health equity, and achieving a zero-carbon future. ESG is central to the Novartis strategy and is key to delivering long-term value to patients, providers, employees and other stakeholders.



To read more about Novartis’ progress toward its ESG targets, click here.


Join Our Newsletter

Get the top workplace fairness news delivered straight to your inbox